Citation Impact
Citing Papers
Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
2018 Standout
Drug resistance in spp., the causative agents of sleeping sickness in man and nagana in cattle
2001
Neglected tropical diseases
2009 Standout
Human African trypanosomiasis
2009
The epidemiology and control of human African trypanosomiasis
2001
Panowamycins A and B, new antitrypanosomal isochromans produced by Streptomyces sp. K07-0010
2012 StandoutNobel
The trypanosomiases
2003
Diagnostics for the developing world
2004 Standout
Antibiotics LL-Z1272 identified as novel inhibitors discriminating bacterial and mitochondrial quinol oxidases
2008 StandoutNobel
The phenomenon of treatment failures in Human African Trypanosomiasis
2001
Update on Myocarditis
2012 Standout
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial
2009
Quantifying the level of under‐detection of Trypanosoma brucei rhodesiense sleeping sickness cases
2005
Novel inhibitors of the trypanosome alternative oxidase inhibit Trypanosoma brucei brucei growth and respiration
2006
In Vitro and in Vivo Antitrypanosomal Activitiy of Two Microbial Metabolites, KS-505a and Alazopeptin
2008 StandoutNobel
Cardiac Involvement with Parasitic Infections
2010
Works of Scott Evans being referenced
Risk factors for treatment failure after melarsoprol for Trypanosoma brucei gambiense trypanosomiasis in Uganda
1999